{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:31:37Z","timestamp":1782865897827,"version":"3.54.5"},"reference-count":25,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,26]],"date-time":"2022-04-26T00:00:00Z","timestamp":1650931200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Ophthalmology Case Reports"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/j.ajoc.2022.101568","type":"journal-article","created":{"date-parts":[[2022,5,4]],"date-time":"2022-05-04T12:24:49Z","timestamp":1651667089000},"page":"101568","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"special_numbering":"C","title":["Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment"],"prefix":"10.1016","volume":"27","author":[{"given":"Tomoko","family":"Noda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1281-5026","authenticated-orcid":false,"given":"Kousuke","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiriko","family":"Hirooka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Kase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajoc.2022.101568_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21165805","article-title":"New perspectives on polycythemia vera: from diagnosis to therapy","volume":"21","author":"Iurlo","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.ajoc.2022.101568_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/bjh.13812","article-title":"Management of polycythaemia vera: a critical review of current data","volume":"172","author":"McMullin","year":"2016","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajoc.2022.101568_bib3","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1182\/blood-2012-07-442012","article-title":"Molecular analysis of patients with polycythemia vera or essential thrombocythemia receiving pegylated interferon alpha-2a","volume":"122","author":"Quintas-Cardama","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.ajoc.2022.101568_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.bjhh.2014.10.001","article-title":"Myeloproliferative neoplasms and the JAK\/STAT signaling pathway: an overview","volume":"37","author":"de Freitas","year":"2015","journal-title":"Rev Bras Hematol Hemoter"},{"key":"10.1016\/j.ajoc.2022.101568_bib5","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/ICB.0000000000000114","article-title":"Jak2 mutation-positive polycythemia vera presenting as central retinal artery occlusion","volume":"9","author":"Dhrami-Gavazi","year":"2015","journal-title":"Retin Cases Brief Rep"},{"key":"10.1016\/j.ajoc.2022.101568_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216417","article-title":"Central retinal artery occlusion as a presenting manifestation of polycythaemia vera","volume":"2016","author":"Rao","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.ajoc.2022.101568_bib7","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/0002-9394(72)90542-9","article-title":"Bilateral, central retinal vein closure as the initial manifestation of polycythemia","volume":"74","author":"Rothstein","year":"1972","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.2147\/OPTH.S33456","article-title":"Impending anterior ischemic optic neuropathy with elements of retinal vein occlusion in a patient on interferon for polycythemia vera","volume":"6","author":"Rue","year":"2012","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/09273948.2011.619680","article-title":"Central serous chorioretinopathy associated with topical latanoprost therapy","volume":"19","author":"Artunay","year":"2011","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/j.ajoc.2022.101568_bib10","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1177\/112067210801800627","article-title":"Serous detachment of macula in cystoid macular edema associated with latanoprost","volume":"18","author":"Ozdemir","year":"2008","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib11","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s10792-007-9137-7","article-title":"Serous retinal detachment in the macula related to latanoprost use","volume":"28","author":"Ozkan","year":"2008","journal-title":"Int Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib12","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1179\/102453309X12583347113410","article-title":"Can ischemia-modified albumin be a valuable indicator of tissue ischemia in polycythemia vera?","volume":"15","author":"Karahan","year":"2010","journal-title":"Hematology"},{"key":"10.1016\/j.ajoc.2022.101568_bib13","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4103\/ojo.OJO_110_2014","article-title":"Polycythemia causing posterior segment vascular occlusions","volume":"10","author":"Ganesan","year":"2017","journal-title":"Oman J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib14","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/aos.13249","article-title":"Non-invasive imaging of retinal blood flow in myeloproliferative neoplasms","volume":"95","author":"Willerslev","year":"2017","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib15","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/bjh.12290","article-title":"Delayed choroidal and retinal blood flow in polycythaemia vera patients with transient ocular blindness: a preliminary study with fluorescein angiography","volume":"161","author":"Yang","year":"2013","journal-title":"Br J Haematol"},{"key":"10.1016\/j.ajoc.2022.101568_bib16","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.ajo.2014.04.021","article-title":"Ultra-widefield imaging with autofluorescence and indocyanine green angiography in central serous chorioretinopathy","volume":"158","author":"Pang","year":"2014","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib17","doi-asserted-by":"crossref","first-page":"e358","DOI":"10.1111\/aos.12059","article-title":"Choroidal vessel diameter in central serous chorioretinopathy","volume":"91","author":"Yang","year":"2013","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0246115","article-title":"Choroidal congestion mouse model: could it serve as a pachychoroid model?","volume":"16","author":"Matsumoto","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/j.ajoc.2022.101568_bib19","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3928\/1542-8877-20000501-19","article-title":"Occult retinal pigment epithelial detachment in hyperviscosity syndrome","volume":"31","author":"Ogata","year":"2000","journal-title":"Ophthalmic Surg Laser"},{"key":"10.1016\/j.ajoc.2022.101568_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1159\/000433449","article-title":"Subfoveal choroidal thickness is associated with blood hematocrit level","volume":"234","author":"Pekel","year":"2015","journal-title":"Ophthalmologica"},{"key":"10.1016\/j.ajoc.2022.101568_bib21","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3389\/fphar.2011.00024","article-title":"Prostacyclin: an inflammatory paradox","volume":"2","author":"Stitham","year":"2011","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ajoc.2022.101568_bib22","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1161\/01.RES.83.7.721","article-title":"A major role for prostacyclin in nitric oxide-induced ocular vasorelaxation in the piglet","volume":"83","author":"Hardy","year":"1998","journal-title":"Circ Res"},{"key":"10.1016\/j.ajoc.2022.101568_bib23","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1254\/jphs.FP0061061","article-title":"Intravenously administered vasodilatory prostaglandins increase retinal and choroidal blood flow in rats","volume":"103","author":"Mori","year":"2007","journal-title":"J Pharmacol Sci"},{"key":"10.1016\/j.ajoc.2022.101568_bib24","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1136\/bjophthalmol-2012-302349","article-title":"Macular choroidal blood flow velocity decreases with regression of acute central serous chorioretinopathy","volume":"97","author":"Saito","year":"2013","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.ajoc.2022.101568_bib25","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/archopht.121.2.225","article-title":"Observation of choroidal circulation using index of erythrocytic velocity","volume":"121","author":"Isono","year":"2003","journal-title":"Arch Ophthalmol"}],"container-title":["American Journal of Ophthalmology Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2451993622003140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T15:03:46Z","timestamp":1762527826000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2451993622003140"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9]]},"references-count":25,"alternative-id":["S2451993622003140"],"URL":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101568","relation":{},"ISSN":["2451-9936"],"issn-type":[{"value":"2451-9936","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subretinal fluid accumulation in a patient with polycythemia vera after receiving a prostaglandin I2 analogue treatment","name":"articletitle","label":"Article Title"},{"value":"American Journal of Ophthalmology Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajoc.2022.101568","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"101568"}}